Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol in Pulmonary Arterial Hypertension
NCT00964678Phase 2Completed
- Sponsor
- Virginia Commonwealth University
- Start
- Jun 2010
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carvedilol in pulmonary arterial hypertension (PAH), sponsored by Virginia Commonwealth University. Started Jun 2010; status: completed.
02
Drugs
carvedilol
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00964678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00964678.